Cargando…

Favipiravir-resistant influenza A virus shows potential for transmission

Favipiravir is a nucleoside analogue which has been licensed to treat influenza in the event of a new pandemic. We previously described a favipiravir resistant influenza A virus generated by in vitro passage in presence of drug with two mutations: K229R in PB1, which conferred resistance at a cost t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldhill, Daniel H., Yan, Ada, Frise, Rebecca, Zhou, Jie, Shelley, Jennifer, Gallego Cortés, Ana, Miah, Shahjahan, Akinbami, Omolola, Galiano, Monica, Zambon, Maria, Lackenby, Angie, Barclay, Wendy S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195362/ https://www.ncbi.nlm.nih.gov/pubmed/34061908 http://dx.doi.org/10.1371/journal.ppat.1008937

Ejemplares similares

Determining the Mutation Bias of Favipiravir in Influenza Virus Using Next-Generation Sequencing
por: Goldhill, Daniel H., et al.
Publicado: (2019)

The mechanism of resistance to favipiravir in influenza
por: Goldhill, Daniel H., et al.
Publicado: (2018)

Contact transmission of influenza virus between ferrets imposes a looser bottleneck than respiratory droplet transmission allowing propagation of antiviral resistance
por: Frise, Rebecca, et al.
Publicado: (2016)

Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness
por: Brookes, Daniel W., et al.
Publicado: (2011)

Characterising viable virus from air exhaled by H1N1 influenza-infected ferrets reveals the importance of haemagglutinin stability for airborne infectivity
por: Singanayagam, Anika, et al.
Publicado: (2020)

A29 Genetic heterogeneity of influenza A (H3N2) viruses in the United Kingdom, 2016–8
por: Galiano, M, et al.
Publicado: (2019)

Levels of Influenza A Virus Defective Viral Genomes Determine Pathogenesis in the BALB/c Mouse Model
por: Penn, Rebecca, et al.
Publicado: (2022)

Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model
por: Lee, Leo Y, et al.
Publicado: (2021)

Mammalian ANP32A and ANP32B Proteins Drive Differential Polymerase Adaptations in Avian Influenza Virus
por: Peacock, Thomas P., et al.
Publicado: (2023)

Feasibility and clinical utility of local rapid Nanopore influenza A virus whole genome sequencing for integrated outbreak management, genotypic resistance detection and timely surveillance
por: Williams, Tom G. S., et al.
Publicado: (2023)

An Influenza A virus can evolve to use human ANP32E through altering polymerase dimerization
por: Sheppard, Carol M., et al.
Publicado: (2023)

Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission
por: Lee, Leo Yi Yang, et al.
Publicado: (2020)

Passage of influenza A/H3N2 viruses in human airway cells removes artefactual variants associated with neuraminidase-mediated binding
por: Brown, Jonathan C., et al.
Publicado: (2020)

Influenza Virus with Increased pH of Hemagglutinin Activation Has Improved Replication in Cell Culture but at the Cost of Infectivity in Human Airway Epithelium
por: Singanayagam, Anika, et al.
Publicado: (2019)

Do point-of-care tests (POCTs) offer a new paradigm for the management of patients with influenza?
por: Dickson, Elizabeth M, et al.
Publicado: (2020)

ANP32 Proteins Are Essential for Influenza Virus Replication in Human Cells
por: Staller, Ecco, et al.
Publicado: (2019)

The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution
por: Ormond, Louise, et al.
Publicado: (2017)

Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19
por: Ison, Michael G., et al.
Publicado: (2021)

A natural variant in ANP32B impairs influenza virus replication in human cells
por: Staller, Ecco, et al.
Publicado: (2021)

Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020
por: Jeffery-Smith, Anna, et al.
Publicado: (2021)

Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007–08
por: Hauge, Siri H., et al.
Publicado: (2009)

Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season
por: Meijer, Adam, et al.
Publicado: (2009)

Nosocomial acquisition of influenza is associated with significant morbidity and mortality: Results of a prospective observational study
por: Snell, L.B., et al.
Publicado: (2022)

Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
por: Shiraki, Kimiyasu, et al.
Publicado: (2020)

ICU admission and favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Fatal Cases of Influenza A(H3N2) in Children: Insights from Whole Genome Sequence Analysis
por: Galiano, Monica, et al.
Publicado: (2012)

End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18
por: Pebody, Richard, et al.
Publicado: (2019)

Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
por: de Ávila, Ana I., et al.
Publicado: (2016)

Monitoring the emergence of community transmission of influenza A/H1N1 2009 in England: a cross sectional opportunistic survey of self sampled telephone callers to NHS Direct
por: Elliot, Alex J, et al.
Publicado: (2009)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infection in England and Scotland, 2009–2010
por: Calatayud, Laurence, et al.
Publicado: (2011)

Anti-Influenza Virus Study of Composite Material with MIL-101(Fe)-Adsorbed Favipiravir
por: Xu, Mengyuan, et al.
Publicado: (2022)

Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir – An insilico approach
por: Anil Kumar, S., et al.
Publicado: (2021)

Species difference in ANP32A underlies influenza A virus polymerase host restriction
por: Long, Jason S., et al.
Publicado: (2016)

Swine ANP32A Supports Avian Influenza Virus Polymerase
por: Peacock, Thomas P., et al.
Publicado: (2020)

Favipiravir in Therapy of Viral Infections
por: Łagocka, Ryta, et al.
Publicado: (2021)

Favipiravir: Hyperuricaemia: case report
Publicado: (2021)

Influenza Pandemics
por: Elderfield, Ruth, et al.
Publicado: (2011)

Species specific differences in use of ANP32 proteins by influenza A virus
por: Long, Jason S, et al.
Publicado: (2019)

Influenza A virus PB1-F2 protein prolongs viral shedding in chickens lengthening the transmission window
por: James, Joe, et al.
Publicado: (2016)

Evolutionary Pathways of the Pandemic Influenza A (H1N1) 2009 in the UK
por: Galiano, Monica, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2mv6soj68hq9firqkacgmfk3o7